AriBioLab Co.,Ltd. (KOSDAQ:261780)
2,640.00
+40.00 (1.54%)
At close: Jun 29, 2026
AriBioLab Revenue
AriBioLab had revenue of 173.16M KRW in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to 331.78M. In the year 2025, AriBioLab had annual revenue of 158.62M, down -57.21%.
Revenue (ttm)
331.78M
Revenue Growth
-57.21%
P/S Ratio
213.77
Revenue / Employee
n/a
Employees
n/a
Market Cap
70.92B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 158.62M | -212.04M | -57.21% |
| Dec 31, 2024 | 370.66M | 76.53M | 26.02% |
| Dec 31, 2023 | 294.12M | 114.64M | 63.87% |
| Dec 31, 2022 | 179.48M | -320.52M | -64.10% |
| Dec 31, 2021 | 500.00M | 422.20M | 542.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CTCBIO | 128.76B |
| KoBioLabs | 71.21B |
| Choong Ang Vaccine Laboratory | 39.19B |
| Naturalendo Tech | 21.69B |
| BIO-FD&C | 18.85B |
| Ark Solutions | 17.95B |
| PanGen Biotech | 13.71B |
| ADBiotech | 12.51B |